Jorge Máspero

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro, Jonathan Corren, Ian Pavord et al. · New England Journal of Medicine · 2018 · 1.8K citations · Full text

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert, Joseph K. Han, Martin Desrosiers et al. · The Lancet · 2019 · 1.4K citations

Asthma, Nasal Polyps, Allergy +7

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

Mario Castro, James Zangrilli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine · 2015 · 1.2K citations

Asthma, Allergy, Allergy Medicine +4

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

Klaus F. Rabe, Parameswaran Nair, Guy Brusselle et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Sally E. Wenzel, Mario Castro, Jonathan Corren et al. · The Lancet · 2016 · 866 citations

Asthma, Pulmonary Care, Allergy +10